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A b s t r A c t
Background: Pregnancy in women with sickle cell anemia is associated with adverse outcome for mother and child, but with 
improvements in medical care, the outcome has greatly improved in developed countries. Despite being the most prevalent 
genetic disease in Africa, sickle‑cell disease, along with its serious health problems in pregnancy, is largely neglected. Objective: 
To determine the effects of preconceptual care on pregnancy outcome among booked patients with homozygous sickle cell 
disease at Aminu Kano Teaching Hospital, Kano, Nigeria. Materials and Methods: A cohort study of the pregnancy outcome, 
among booked 39 pregnant women with homozygous sickle cell disease (Hbss), who had preconception care, and an equal 
number of booked pregnant women with homozygous sickle cell disease (Hbss), who did not have preconception care (controls), 
at Aminu Kano Teaching Hospital, between January 2000 and December 2006. Results: There was no statistically significant 
difference in the occurrence of complications between the two groups, but complications occurred with less frequency among 
the cases compared to the controls. Conclusion: This study suggest that preconception care and effective prenatal care by a 
multidisciplinary team, and delivery in a hospital which is accustomed to management of sickle cell disease and its complications, 
is associated with good pregnancy outcome in women with sickle cell anemia in pregnancy.
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The high prevalence of sickle cell disease in pregnancy 
in recent studies has been attributed to improvement 
in medical care, with resultant increase in the number 
of women who survive into adulthood and get pregnant, 
which makes it a disorder of public health concern in 
today’s obstetrics.[1-4]
Sickle cell disease was first described in literature in a paper 
titled “Peculiar elongated and sickle-shaped red corpuscles 
in a case of severe anemia,” which is a clear description 
of what happens to the hemoglobin molecule when 
deoxygenated.[5]
Sickle cell disease is common among the black race, with 
the highest incidence in the world reported from Uganda, 
in East Africa.[6] The hemoglobinopathies that are commonly 
encountered in pregnancy are homozygous sickle cell disease 
(Hbss) also known as sickle cell anemia, heterozygous sickle 
cell disease also known as sickle cell hemoglobin C (Hbsc), 
and sickle cell ß-thalassemia (Sß-thal).[2] The most frequently 
encountered variant is sickle cell anemia (Hbss).[2,7-11]
Sickle cell anemia (Hbss) occurs when there is a substitution 
of one amino acid by another, namely valine for glutamic 
acid at position 6 on the ß-chain.[2] Valine is neutrally 
charged while glutamic acid has a negative charge. The 
change in electronegativity allows hydrophobic binding 
when hemoglobin is deoxygenated, causing the classic 
distortion in the molecule, which is remedied when the 
hemoglobin is deoxygenated initially, but not after recurrent 
episodes.[1,2] This leads to gross reduction in the lifespan of 
these red blood corpuscles from the expected 120 days in 
the unaffected population to 10 to 20 days, with the sequel 
of chronic anemia in these patients.[2,12-14]
The increase in oxygen consumption, blood viscosity 
and red cell mass, which occur as normal physiological 
changes in pregnancy, put an extra demand on a woman 
with sickle cell disease and increase the frequency of crises 
and other complications,[2] which makes the management 
of pregnancies in women with sickle cell disease to be 
extremely taskful.[15-21] This has prompted some obstetricians 
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in the past to advise them to avoid pregnancy or opt for 
elective termination of pregnancy.[4]
Early reports on the outcome of pregnancy in women with 
sickle cell anemia, depicted an almost universal adverse 
outcome for mother and child,[7,8] but with improvements in 
medical care, especially the introduction of preconception 
care, the outcome has greatly improved.[1,14] This 
improvement in fetomaternal outcome is poorly reflected in 
sub-Saharan Africa where the prevalence and complications 
of sickle cell disease in pregnancy is highest in the world, 
and a maternal mortality rate of 0.38 - 1.29/100,000 births 
and perinatal mortality rate of 1.21 - 2.50/100,000 births[7-11] 
are still being reported. This has been attributed to poor 
utilization of the scanty medical and antenatal care facilities, 
and poor or non-existence of preconception care facilities 
in most communities in sub-Saharan Africa.[14]
It is against this background that this study was 
designed, to assess the effects of preconception care and 
multidisciplinary team management on pregnancy outcome 
in women with sickle cell anemia in our institution, 
and to make recommendations that will improve future 
management policies and outcome.
MATeRIALs AnD MeTHODs
This is a prospective comparative study of 39 booked 
pregnant women with homozygous sickle cell disease (HbSS), 
who attended our sickle cell clinic in the non-pregnant state, 
had preconception care, and were referred from our sickle 
cell clinic to the booking clinic (cases), and an equal number 
of booked, age, parity and socio-economic status- matched 
pregnant women with homozygous sickle cell disease (HbSS), 
who did not have preconception care (controls). In both 
groups, the women were recruited at 16 weeks gestation 
after they gave an informed consent, and were regular in the 
antenatal clinic, delivered in our labor ward, and were followed 
up for the first 7 days post-delivery, between January 2000 
and December 2006 at Aminu Kano Teaching Hospital, Kano, 
Nigeria. The women in both groups were managed by a 
multidisciplinary team, which consisted of the obstetricians, 
hematologists, sickle cell physicians, pediatricians, dieticians, 
anesthetists, and nursing staff who are trained in the 
management of patients with sickle cell disease in pregnancy.
The controls were the first women with sickle cell anemia 
(HbSS) who booked after a recruited woman and met the 
recruitment criteria. Age, parity, and socio-economic status 
were matched in the two groups, and women who carried 
multiple pregnancies were excluded because they are 
variables that may change many of the features associated 
with pregnancy outcome.[1,2]
Management of the cases and controls included provision 
of information and education about sickle cell disease, 
improvement in nutritional status and the use of daily folic 
acid and multivitamins, malaria prevention, which involved 
the use of malaria chemoprophylaxis (Proguanil 100 mg 
per oral daily) and sleeping under insecticide-treated 
mosquito nets. Febrile malaria infection was confirmed 
by peripheral blood smear for malaria parasites, and the 
women were treated with Artemesin-based combination 
therapy. Screening for and treatment of cases of urinary 
tract infection (mid stream urine for microscopy, culture 
and sensitivity) and pneumonia (chest X-ray), adequate 
fluid intake, and blood transfusion where required. Anemia 
was treated with blood transfusion if an operation is 
contemplated, or whenever the hemoglobin concentration 
was less than 6 g/dl, in-order to prevent crises and 
anemic heart failure.[3,4,11] Labour was managed using 
psychotherapy, partograph, and electronic fetal monitoring, 
liberal analgesia and oxytocin augmentation was employed 
to avoid pain and prolonged labor. Intravenous hydration 
was ensured, and intravenous antibiotics were commenced 
with rupture of the fetal membranes. Where necessary, 
episiotomy and/or instrumental delivery was employed to 
avoid delayed second stage of labor. Active management of 
the third stage of labor was employed to avoid postpartum 
hemorrhage. The women were advised to observe adequate 
rest with close monitoring and care in the puerperium.
For the purpose of this study, preconceptual care is the 
medical care that is given to a woman before pregnancy, 
in-order to manage conditions and behaviors, which could 
be a risk to her or her baby. Sickle cell crises refers to 
severe acute conditions like vaso-occlusive (painful) crises, 
hemolytic crises, sequestration crises and aplastic crises, 
occurring in patients with sickle cell disease. Hemolytic 
crises are acute accelerated drops in hemoglobin level, 
and painful crises are typical sickle-related bone pain of 
sufficient severity to require narcotic analgesia. Severe 
anemia	was	 taken	as	hemoglobin	 concentration	of	40%	or	
more below the steady state level, antepartum hemorrhage 
(APH) as bleeding per vaginam after 28 weeks of pregnancy 
and before delivery of the fetus, postpartum hemorrhage 
(PPH) as blood loss of 500 ml or more following vaginal 
delivery, and 1000 ml or more following cesarean section. 
Febrile malaria infection refers to a temperature rise of 
37.5°C or more due to malaria infection in the absence of 
symptoms/signs of other infections. Malaria infection was 
said to be present if there was at least one asexual parasite 
per 200 white blood cells in a thick film while a negative 
slide was one in which no asexual form was found after 
counting 1000 white blood cells. Pneumonia was defined as 
pulmonary symptoms and signs that were associated with a 
new pulmonary infiltrate on chest X-ray that was done with 
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abdominal shielding while urinary tract infection referred to 
urinary symptoms with positive urine culture. Pre-eclampsia 
was the development of hypertension and proteinuria in the 
second half of pregnancy in a woman who was normotensive 
and non-proteinuric in the first half of pregnancy. Proteinuria 
was defined by dipstick as trace proteinuria or more. The 
difference in definition is because of the less concentrated 
urine in homozygous sickle cell disease.[1] Retained placenta 
was said to occur if the placenta has not been delivered 
5 minutes after the delivery of the baby because active 
management of the third stage of labor was employed in 
the management of all the patients. Spontaneous abortion 
was taken as demise of the pregnancy before 28 weeks of 
gestation while preterm delivery was termination of the 
pregnancy between 28 weeks and 36 completed weeks of 
gestation. Low birth weight (Lbwt) was taken as birth weight 
of 2.5 kg or less, and birth asphyxia as an APGAR score of 
less than 7 at 5 minutes of life. Pregnancy was confirmed in 
all the cases by ultrasound scanning.
At booking, as part of the routine tests, hemoglobin 
genotype is determined by hemoglobin electrophoresis that 
is performed in the hematology laboratory in our hospital. 
The socio-economic status of the women was derived from 
their educational status and husband’s occupation.
The study variables of interest were pregnancy and delivery 
complications: Spontaneous abortions, crises, infections, 
pre-eclampsia/eclampsia, severe anemia, antepartum and 
postpartum hemorrhages, retained placenta, birth asphyxia, 
preterm delivery, low birth weight babies, mean gestational 
age at delivery, mean birth weight, and perinatal deaths 
(stillbirths and early neonatal deaths). Mode of delivery was 
spontaneous vaginal delivery (SVD), instrumental vaginal 
delivery, and cesarean section (C/S).
Sample size determination
Odum et al,[8] in a study done in Lagos, Nigeria, found a 
complication	rate	of	96.6%,	among	pregnant	women	with	sickle	
cell anemia in pregnancy, who did not receive preconception 
care. Using the result obtained in this study, and accepting 
a	 study	power	of	 80%,	 confidence	 interval	of	 90%,	 study	 to	
control	ratio	of	1:1,	and	an	acceptable	dropout	rate	of	10%,	
the sample size for each group was then determined using the 
statistical formula for comparison of proportions as follows:
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preconception care among women with sickle cell  anemia 











Zα=1.96; for the significance level of 0.05, that is used in 
this study.
Zβ=0.84;	for	the	power	of	the	test	of	80%	that	was	used	in	
this study to compare  between the 2 groups.
f=the proportion of study participants who are expected to 
be	lost	to	follow‑up	in	this	study	(attrition)=10%	(0.1)
Therefore, the minimum sample size required for each 
study group for it to be statistically significant was:
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= 1.1 × 13.42
= 15 subjects per group (not sufficient to propound null 
hypothesis)
= 15 × 2.5 = 39 subjects per group approximately.
The data obtained were recorded on a pro-forma and were 
entered into the computer using EPI INFO version 6.0 
software packages. Statistical analysis was done using 
Chi-square test to compare qualitative variables for 
significant differences while student’s t-test was used to 
compare means and standard deviations. Odds ratio (OR) 
and	 95%	 confidence	 interval	 (CI)	 were	 determined	 where	
appropriate.
ResULTs
Among the cases and the controls, the mean age of 
the women was 23.4 (1.5) years with a range of 14 to 
30 years, and the mean parity was 3.0 (0.62) with a 
range of 0 to 6. The mean hemoglobin concentration 
at 34 weeks gestation of 7.75 (0.54) g/dl among the 
cases and 7.68 (0.75) g/dl among the controls did not 
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show statistically significant difference (t=0.44, df=72, 
P=0.660). There was no statistically significant difference 
in the prevalence of spontaneous abortions between the 
two groups (OR=0.49, CI=0.02 - 7.31, P=1.000). Vaginal 
delivery (OR=1.62, CI=0.53 - 5.00, P=0.492), instrumental 
deliveries (OR=0.85, CI=0.31 - 2.33, P=0.909), and 
cesarean delivery (OR=0.83, CI=0.25 - 2.78, P=0.250) 
did not show statistically significant difference between 
the	 two	 groups.	 Among	 the	 cases,	 62.5%	 (5/8)	 of	 the	
cesarean	 sections	were	 carried	out	 as	 elective	 and	37.5%	
(3/8) as emergences. Indications for elective cesarean 
section were previous cesarean section (2 patients), breech 
presentation (2 patients), and placenta previa (1 patient) 
while for emergency cesarean section were failed 
induction of labor (1 patient), fetal distress (1 patient), 
and severe pre-eclampsia (1 patient). Among the controls, 
55.6%	 (5/9)	 of	 the	 cesarean	 sections	 were	 carried	 out	 as	
elective	 and	 44.4%	 (4/9)	 as	 emergencies.	 Indications	 for	
elective cesarean section were previous cesarean section 
(2 patient), placenta previa (2 patients) and transverse lie 
(1 patient) while for emergency cesarean section were 
severe pre-eclampsia (2 patients), fetal distress (1 patient), 
failed induction of labor (1 patients). The mean gestational 
age at delivery (t=7.40, df=67, P<0.001) and the mean 
birth weight of the babies (t=3.04, df=67, P=0.003) were 
statistically significantly higher among the cases. Preterm 
delivery (OR=0.31, CI=0.01 - 3.55, P=0.358), low birth 
weight babies (OR=0.68, CI=0.24 - 1.87, P=0.548), birth 
asphyxia (OR=0.46, CI=0.65 - 0.3.21, P=0.430), perinatal 
mortality (OR=0.47, CI=0.02 - 7.12, P=0.430), and 
maternal mortality (OR=0.00, CI=0.00 – 17.66, P=1.000) 
did not show statistically significant difference between 
the cases and the controls, but occurred more frequently 
among the controls. There were 2 neonatal deaths among 
the controls, but one among the cases from birth asphyxia. 
There was one maternal death from severe pre-eclampsia 
(26 maternal deaths/1000 deliveries) among the controls, 
and none among the cases Table 1.
There was no statistically significant difference in the 
frequency of hemolytic crises (OR=0.63, CI=0.07 - 5.06, 
P=0.674), bone pain crises (OR=0.36, CI=0.09 - 1.31, 
P=0.142), pneumonia (OR=0.47, CI=0.02 - 7.12, 
P=0.615), urinary tract infection (OR=0.97, CI=0.18 - 
5.15, P=1.000), malaria infection (OR=0.83, CI=0.29 - 
2.35, P=0.881), pre-eclampsia (OR=0.55, CI=0.09 - 2.95, 
P=0.480), severe anemia (OR=0.46, CI=0.05 - 3.21, 
P=0.430), antepartum hemorrhage (OR=0.63, CI=0.07 - 
5.06, P=0.674), postpartum hemorrhage (OR=1.25, 
CI=0.26 - 6.20, P=1.000), retained placenta (OR=0.31, 
CI=0.01 - 3.58, P=0.358) between the two groups. There 
was no case of eclampsia among the cases and the controls 
Table 2.
DIscUssIOn
The mean age of the pregnant women with sickle cell 
anemia in this study of 23.4 years is lower while the mean 
parity of 3.0 is higher than the mean age of 27.3 years and 
mean parity of 1.7 reported from Benin City in Southern 
Nigeria.[4] This may probably be due to an early marriage 
in our predominantly Islamic society in North western 
Nigeria[22] while delay in marriage in Benin City, which is 
a predominantly Christian society, has been attributed 
to female educational pursuits and economic attainment 
before marriage.[4]
The higher mean parity among women, with sickle cell 
anemia in recent studies, has been attributed to improved 
antenatal and health care delivery services,[3,4,14] and may 
herald the advent of high parity among women with sickle 
cell anemia in pregnancy.
The frequency of spontaneous abortion did not show 
significant difference between the cases and the controls, 
probably because of late booking after the first trimester, 
which is the peak period of spontaneous abortion.[4] 
Serjeant et al,[1]	 found	a	spontaneous	abortion	rate	of	80%	
Table 1: Pregnancy outcome




OR CI P 
value
Spontaneous abortion 1 (2.6) 2 (5.1) 0.49 0.02 ‑ 7.31 1.000
Mode of delivery n=38 n=37
Spontaneous vaginal 
delivery
13 (34.2) 9 (24.3) 1.62 0.53 ‑ 5.00 0.492
Instrumental delivery 18 (47.4) 19 (51.4) 0.85 0.31 ‑ 2.33 0.909
Cesarean section 8 (21.1) 9 (24.3) 0.83 0.25 ‑ 2.78
New born
Mean gestational age 37.5 (2.8) 36.0 (2.5) – – <0.001
Mean birth weight 2.8 (0.5) 2.4 (0.6) – – 0.003
Preterm delivery 1 (2.6) 3 (8.1) 0.31 0.01 ‑ 3.58 0.358
Low birth weight 20 (52.6) 23 (62.2) 0.68 0.24 ‑ 1.87 0.548
Birth asphyxia 2 (5.3) 4 (10.8.) 0.46 0.05 ‑ 3.21 0.430
Perinatal mortality
Neonatal deaths 1 (2.6) 2 (5.4) 0.47 0.02 ‑ 7.12 0.615
n=39 n=39
Maternal mortality – 1 (2.6) 0.00 0.00 ‑ 17.66 1.000
Table 2: Complications during pregnancy, labor, and the first 
7 days of puerperium




OR CI P 
value
Crises
Hemolytic 2 (5.3) 3 (8.1) 0.63 0.07 ‑ 5.06 0.674
Bone pain 5 (13.2) 11 (29.7) 0.36 0.09 ‑ 1.31 0.142
Infections
Pneumonia 1 (2.6) 2 (5.4) 0.47 0.02 ‑ 7.12 0.615
Urinary tract infection 4 (10.5) 4 (10.8) 0.97 0.18 ‑ 5.15 1.000
Malaria fever 23 (60.5) 24 (64.9) 0.83 0.29 ‑ 2.35 0.881
Pre‑eclampsia 3 (7.9) 5 (13.5) 0.55 0.09 ‑ 2.95 0.480
Severe anemia 2 (5.3) 4 (10.8) 0.46 0.05 ‑ 3.21 0.430
Antepartum hemorrhage 2 (5.3) 3 (8.1) 0.63 0.07 ‑ 5.06 0.674
Postpartum hemorrhage 5 (13.2) 4 (10.8) 1.25 0.26 ‑ 6.20 1.000 
Retained placenta 1 (2.6) 3 (8.1) 0.31 0.01 ‑ 3.58 0.358
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among women with sickle cell anemia in pregnancy before 
12 weeks of gestation, which may explain the low frequency 
of spontaneous abortion in this study and other studies 
from sub-Saharan Africa[4] where majority of the women 
book late for antenatal care.
The mean hemoglobin concentration at 34 weeks gestation, 
which did not show any significant difference between 
the cases and the controls, may probably be because the 
women in the two groups had hematinics and malaria 
chemoprophylaxis in pregnancy, and were advised to sleep 
under insecticide-treated nets during the critical period of 
16th to 36th weeks of gestation. The low mean hemoglobin 
concentration of 7.75 g/dl among the cases and 7.68 g/dl 
among the controls in this study is similar to 7.71 - 7.78 g/dl 
that was reported in other studies from West Africa,[4,8,14,18] 
7.65 g/dl from India,[3] and 7.50 g/dl from West Indies.[1] This 
may be due to the shorter life span of the red blood cells, from 
120 days in the normal population to 10-20 days in women 
with sickle cell anemia. This physiological process of low 
mean hemoglobin concentration is meant to avoid increased 
viscosity of the blood, which could precipitate crises.[2]
The higher mean hemoglobin concentration in some 
studies from developed countries[23,24] has been attributed 
to routine prophylactic top-up blood transfusion from 20th 
week of gestation to ensure adequate maternal hemoglobin 
levels with HbAA red cells, in-order to reduce the frequency 
of crises and ensure better maternal well-being.[13,16-21] This is 
not the policy in Aminu Kano Teaching Hospital and in some 
health facilities in West Africa[4] because it may improve 
maternal well-being, but it does not significantly improve 
the perinatal outcome,[1-4,13-19] and it may be associated with 
the risk of developing rare antibodies, which may adversely 
affect cross-matching of donor’s blood and increase the 
frequency of blood transfusion reactions.[2,13-19]
Bone pain crises were commoner than hemolytic crises, 
which agrees with the findings of other authors.[3,4,7,8] This 
may be due to the increase in blood viscosity and red 
cell mass, which occur as normal physiological changes 
in pregnancy.[2] The frequency of bone pain crises and 
hemolytic crises, which did not show any significant 
difference between the two groups in this study, may be the 
effect of active prenatal care by a multidisciplinary team that 
was given to the women in the two groups, but the lower 
frequency of these complications among the cases may 
be the effect of preconceptual care that was given to the 
women in the study group, which was also the experience 
of Ogedengbe et al,[10] from Lagos, Nigeria.
There was no statistically significant difference in the 
occurrence of infectious morbidities between the two 
groups, which agrees with other similar studies from West 
Africa.[14,18] This may probably be because the women in the 
two groups were managed by a multidisciplinary team, had 
hematinics and malaria chemoprophylaxis in pregnancy, 
with treatment for malaria infection in event of malaria fever, 
screening for pneumonia, which was based on symptoms 
and signs from history and physical examination at each 
visit, and urinary tract infection, and early intervention with 
appropriate antibiotics in event of infection. Also, they were 
encouraged to sleep under insecticide-treated mosquito 
nets. These present day interventions may have accounted 
for why it does not agree with the poor findings in earlier 
studies from Nigeria while preconceptual care may account 
for the lower frequency of infectious morbidities among the 
cases, which agrees with other recent similar studies from 
West Africa.[14,18] Malaria infection with Plasmodium falciarum 
was the commonest morbidity, probably because this study 
was conducted in a malaria endemic area.[4]
The frequency of vaginal, instrumental, and cesarean 
deliveries did not show statistically significant difference 
between the two groups, which is also the experience of 
other authors.[14] This may be because the women in the 
two groups were managed by a multidisciplinary team, 
which ensured that they were in good state of health at the 
time of delivery, and labor was managed using partograph 
and electronic fetal monitoring as well as augmentation of 
labor with oxytocin to avoid prolonged labor. This does 
not agree with the findings of earlier studies from West 
Africa[7] where the poor state of the women made cesarean 
delivery to be the commoner mode of delivery, which has 
been attributed to inadequate management of the patients 
because the present day interventions were not employed 
in their management.
The high number of instrumental vaginal deliveries in the 
two groups agrees with the findings of other studies,[7-10,14] 
and is attributed to prophylactic forceps and vacuum 
deliveries that were employed to minimize maternal efforts 
in the second stage of labor as the stress could precipitate 
crises.[1]
The frequency of retained placenta did not show significant 
difference between the cases and the controls, which 
agree with similar studies from sub-Saharan Africa.[14,18] 
The high prevalence of retained placenta among women 
with sickle cell anemia in pregnancy has been attributed to 
vaso-occlusive crises, which cause sickle-induced scarring of 
the endometrium from ischemia that leads to binding of the 
placenta more firmly to the underlying uterus.[1] This may 
explain the lower frequency of retained placenta among the 
cases who had preconceptual care compared to the controls 
in this study, and among the women in this study who had 
active prenatal care by a multidisciplinary team, compared 
to earlier studies from sub-Saharan Africa.[7]
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The frequency of neonatal complications of preterm 
delivery, low birth weight babies, and birth asphyxia, as well 
as obstetric and medical complications of severe anemia, 
pre-eclampsia, antepartum and postpartum hemorrhage 
did not show any significant difference between the two 
groups, probably because the women in the two groups 
had effective and active prenatal care by experienced 
multidisciplinary team, and delivered in our hospital, which 
is accustomed to the management of women with sickle 
cell anemia in pregnancy. This agrees with recent similar 
studies from West Africa.[14,18] The lower frequency of 
complications among the cases may be because the women 
had preconceptual care.
The high frequency of low birth weight babies among the 
cases and controls agree with the findings of Serjeant et al,[1] 
who found that better maternal health during pregnancy, 
despite reducing the frequency of maternal painful crises 
and degree of anemia, had no effect on birth weight because 
the physiologic demands of pregnancy will increase the 
frequency of vaso-occlusive crises and chronic anemia more 
than in the non-pregnant state, with resultant chronic fetal 
hypoxia from uteroplacental insufficiency.
Although differences in patient’s characteristics may have 
contributed, preconceptual care may be responsible for 
the lower frequency of preterm delivery among the cases, 
which may account for why the mean gestational age and 
the mean birth weight among the cases were significantly 
higher than among the controls. This agrees with other 
studies.[10,14]
Perinatal and maternal mortality did not show any significant 
difference between the two groups, probably because of 
effective and active prenatal care by a multidisciplinary 
team, with appropriate and relevant prenatal interventions, 
and management of labor and puerperium by experienced 
team of specialist obstetricians, with back up by relevant 
medical staff in the two groups. The maternal mortality rate 
of	2.6%	 (1/39)	among	the	controls,	who	had	only	prenatal	
multidisciplinary	 team	 management,	 is	 similar	 to	 1.8%	
(7/42) that was reported in a recent similar study by Rahimy 
et al,[14] from Cotonou, in Benin Republic, a neighboring 
West	 African	 country,	 but	 did	 not	 agree	with	 9.2%	 (4/44)	
that was reported in an earlier study in 1992 by Dare et al,[7] 
from Ile-Ife from south western Nigeria. The poor pregnancy 
outcomes, previously reported for sickle cell disease in 
pregnancy in West Africa, reflect inadequate management 
of these patients rather than the intrinsic severity of the 
disease.[14]
There was no maternal mortality among the women 
that had preconceptual care, in addition to prenatal care 
by a multidisciplinary team in this study. This agrees 
with the findings of Ogedengbe et al,[10] where booked 
women who had preconceptual care had no maternal 
mortality	 as	 against	 33.3%	 (2/6)	 among	 booked	 women	
who did not have preconceptual care, and booked women 
who had preconceptual care had better pregnancy 
outcome, compared to booked women who did not have 
preconceptual care. This may be because preconception 
care may have ensured that the women were in good state 
of health when they got pregnant, which is our strongest 
defense against the disorder in pregnancy.[1] Rahimy et al,[14] 
in West Africa, found that the pregnancy outcomes among 
women with sickle cell disease that had preconceptual care, 
and were managed by an experienced multidisciplinary 
team, was similar to that of developed countries.
Public health education about the importance of 
preconception care, early booking for antenatal care by 
a multidisciplinary team, and hospital delivery should be 
intensified, especially in sub-Saharan Africa where as a 
result of poverty, ignorance, and socio-cultural barriers to 
utilization of the available health care facilities, most of the 
women do not have preconception care, and book late or 
are unbooked for antenatal care.[4,7-10]
Measures to prevent sickle cell disease in the community 
and hence in pregnancy, like premarital genetic counseling, 
the use of the adult human stem cell therapy, bone 
marrow/cord blood transplant, pre-implantation selection 
should be intensified.[19,25] Human stem cell research is 
still in the rudimentary stage in most developing countries 
today, and when available, it may be unaffordable by 
majority of the populace. Premarital genetic counseling, 
which is affordable, and can be made widely available in 
low resource settings, should be encouraged in developing 
countries like Nigeria.
Prenatal diagnosis and selective termination of pregnancies 
carrying affected fetuses may not be feasible in our center 
because of the restrictive abortion laws in Nigeria[26] and its 
unacceptability in our predominantly Islamic community.
Large multicenter studies will be required to confirm the 
findings of this hospital-based study.
cOncLUsIOn AnD RecOMMenDATIOns
Pregnant women with sickle cell anemia, who had 
preconceptual care in addition to prenatal care by a 
multidisciplinary team, and delivery with follow-up in the 
puerperium, had fewer pregnancy complications when 
compared to their counterparts who had only prenatal care 
by a multidisciplinary team, and delivery with follow-up in 
the puerperium at Aminu Kano Teaching Hospital.
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The current trend in sub-Saharan Africa should be that of 
preconception care, expert prenatal care with effective 
interventions by a multidisciplinary team, and delivery with 
follow-up in the puerperium at an institution accustomed to 
management of sickle cell disease and its complications in 
order to reduce fetomaternal morbidity and mortality from 
this condition. This will contribute towards the achievement 
of Millennium Development Goals (MDGs) 4 and 5.
Provision of free or subsidized medical/antenatal care and 
hospital delivery will be needed in order to achieve this 
goal. Premarital genetic counseling should be encouraged 
in the community in order to reduce the future population 
of women with sickle cell disease.
RefeRences
1. Serjeant GR, Loy LL, Hambleton IR, Thame M. Outcome of pregnancy in 
Homozygous sickle cell disease. Obstet Gynaecol 2004;103:1278-85.
2. Dent K. Perinatal Review- Sickle Cell Disease. Available from: http://
www.perinatal.nhs.uk/reviews/haemoglobinopathies/sickle.htm. 
[Last cited on 2007 Jan 11].
3. Sowane AS, Zodpey SP. Pregnancy outcome in women with sickle cell 
disease/trait. J Obstet Gynaecol India 2005;55:415-8.
4. Omo-Aghoja LO, Okonofua FE. Pregnancy outcome in women with 
sickle cell- A five year review. Niger Postgrad Med J 2007;14:151-4.
5. Herrick JB. Peculiar elongated and sickled red blood corpuscles in a 
case of severe anaemia. Arch Intern Med 1910;6:517.
6. Lawson JB. Sickle cell disease in pregnancy. In: Lawson JB, Stewart DB, 
editors. Obstetrics and Gynaecology in the tropics and developing 
countries. London: Edward Arnold Publishers; 1967. p. 100-19.
7. Dare FO, Makinde OO, Fasubaa OB. Obstetric performance of sickle 
cell disease patients and homozygous haemoglobin C disease patients 
in Ile-Ife, Nigeria. Int J Obstet Gynaecol 1992;37:163-8.
8. Odum CU, Anorlu RI, Dim SI, Oyekan TO. Pregnancy outcome in Hbss 
cell disease in Lagos, Nigeria. West Afr J Med 2002;21:19-23.
9. Idrisa A, Omigbodun OA, Adeleye JA. Pregnancy in haemoglobin sickle 
cell patients at the University College Hospital, Ibadan. Int J Obstet 
Gynaecol 1992;38:83-6.
10. Ogedengbe OK, Akinyanju O. The pattern of sickle cell in pregnancy 
in Lagos, Nigeria. West Afr J Med 1993;12:96-100.
11. Omu AE, Tabowei O, Okpere EE. The effect of sickle cell on obstetric 
performance in a Nigerian community. Tropical J Med 1982;34:47-50.
12. Ngoh NN, Fokoua S, Nkemayim DC, Doh AS. Sickle cell disease in 
pregnancy. Clinics in mother and child health. 2004;1:53-60.
13. Ocheni S, Onah HE, Ibegbulam OG, Eze MI. Pregnancy outcomes 
in patients with sickle cell disease in Enugu, Nigeria. Niger J Med 
2007;16:227-30.
14. Rahimy MC, Gangbo A, Adjou R, Deguenon C, Goussanou S, Alihonu E. 
Effect of active prenatal management on pregnancy outcome in sickle 
cell disease in an African setting. Am Soc Haematol 2000;96:1685-9.
15. Sun PM, Wilburn W, Raynor D, Jamieson D. Sickle cell disease in 
pregnancy. Twenty years of experience at Grady Memorial Hospital, 
Atlanta Georgia. Am J Obstet Gynaecol 2001;184:1127-39.
16. Cunningham FM, Pritchard JA, Mason R. Results with and without 
prophylactic blood transfusions. Obstet Gynaecol 1983;62:419.
17. Howard RJ, Tuck SM, Pearsohn TC. Pregnancy in sickle cell disease in 
UK: Result of a multicentric survey of the effect of blood transfusion on 
maternal and fetal outcome. BR J Obstet Gynaecol 1995;102:947-51.
18. Afolabi BB, Iwuala NC, Iwuala IC, Ogedengbe OK. Morbidity and 
mortality in sickle cell pregnancies in Lagos, Nigeria: A case control 
study. J Obstet Gynaecol 2009;29:104-6.
19. Ndugwa CM. Pregnancy in sickle cell anaemia in Uganda (1971-1980). 
East Afr Med J 1982;59:320-6.
20. Milner PF, Jones BR, Dobler J. Outcome of pregnancy in sickle cell 
anaemia and sickle cell HbC. Am J Obstet Gynaecol 1980;138:239-45.
21. Pritchard JA, Scott DE, Whalley PJ, Cunningham FG, Mason R. The 
effects of maternal sickle cell haemoglobinopathies and sickle cell trait 
on reproductive performance. Am J Obstet Gynaecol 1973;117:662-70.
22. Omole-Ohonsi A, Attah RA. Outcome of caesarean delivery at Aminu 
Kano Teaching Hospital. Kanem J Med Sci 2009;3:36-9.
23. Leborgne SY, Janky E, Venditelli J. Sickle cell anaemia and pregnancy: 
Review of 68 cases in Guadeloupe. J Gynaecol Obstet Biol Reprod 
2000;29:86-93.
24. Koshy M. Sickle cell disease and pregnancy. Blood Rev 1995;9:157-64.
25. Xu K, Shi ZM, Veeck LL, Hughes MR, Rosenwaks Z. First unaffected 
pregnancy using pre-implantation diagnosis for sickle cell anaemia. 
JAMA 1999;281:1701-6.
26. Oye-Adeniran BA, Umoh AV, Nnatu SN. Complications of unsafe 
abortion: A case study and the need for abortion law reform in 
Nigeria. Reprod Health Matters 2002;10:18-21.
Announcement
Android App
A free application to browse and search the journal’s content is now available for Android based 
mobiles and devices. The application provides “Table of Contents” of the latest issues, which 
are stored on the device for future offline browsing. Internet connection is required to access the 
back issues and search facility. The application is compatible with all the versions of Android. The 
application can be downloaded from https://market.android.com/details?id=comm.app.medknow. 
For suggestions and comments do write back to us.
How to cite this article: Omole-Ohonsi A, Ashimi OA, Aiyedun TA. 
Preconception care and sickle cell anemia in pregnancy. J Basic Clin Reprod 
Sci 2012;1:12-8.
Source of Support: Nil, Conflict of Interest: None declared
